SANTA CLARA, Calif. — Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the […]

BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience. Thierry Bernard Frank H. Laukien, the Chairman, President and CEO […]

REDWOOD CITY, Calif. — Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc., effectively concluding a multi-year legal challenge and solidifying the invalidation of two Agilent CRISPR-related patents that claimed a widely used […]

PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. The collaboration brings together ALS Therapy Development Institute (ALS TDI), LifeArc, and Axol Bioscience to develop high-quality induced pluripotent […]

Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and […]

Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of […]

Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical genomics community PLEASANTON, Calif.  — n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al’Khafaji […]

LumaCyte Analytical Method Included in Newly Published ISO Global Standard for Viral Vector Quantification LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921‑2:2026: Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors. Published earlier this […]

Group photo of representatives for the agreement signature. From left to right: Prof. KWONG Lai Wan, Dora, Clinical Professor, Department of Clinical Oncology, HKU; Dr. Paul WANG, Director of Techno-Entrepreneurship Core, HKU; Dr. ZHANG Yong, CEO of BiomOrgan Limited; Prof. YUEN Kwok-Yung, Chair Professor, Department of Microbiology, HKU & Managing Director, CVVT; Prof. ZHOU Jie, […]

COLUMBIA, Md. — Shimadzu Scientific Instruments Inc., a Shimadzu Group company, has officially opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications and lab automation solutions tailored to the needs of pharmaceutical […]